Currently, diagnosis of type I allergy is performed using crude allergen extracts, which allow the identification of the allergen-containing source responsible for type I allergic symptoms (e.g., allergic rhino-conjunctivitis, asthma) but not the disease-eliciting molecules...
Keywords: component-resolved diagnosis (CRD), cross-sensitization, hypoallergenic derivatives, microarrayed allergens, recombinant allergens, specific immunotherapy, type I allergy
02/2006 | Clinical Chemical Laboratory Medicine, Walter de GruyterDerzeit werden zur Diagnose der Typ I-Allergie Aller-genextrakte herangezogen, die zwar die auslösende Allergenquelle, nicht aber die für die Symptome (allergische Rhinokonjunktivitis, Asthma bronchiale) verantwortlichen allergenen Moleküle identifizieren können...
Keywords: Allergenchip, hypoallergene Derivate, komponentenspezifische Diagnose, Kreuzsensibilisierung, rekombinante Allergene, spezifische Immuntherapie, Typ I-Allergie, component resolved diagnosis (CRD), cross-sensitization, hypoallergenic derivatives, microarrayed allergens, recombinant allergens, specific immunotherapy, type I allergy
08/2005 | LaboratoriumsMedizin, Walter de GruyterAllergen-specific immunotherapy is currently based on the administration of allergen extracts containing natural allergens...
Keywords: allergy, allergy vaccines, recombinant allergens, specific immunotherapy
07/2008 | Biological Chemistry, Walter de Gruyter